Sharechat Logo

Tower appoints new director

Thursday 18th December 2003

Text too small?
Tower has appointed Bill Falconer as a board director.

Falconer is a Cambridge, New Zealand based company director. He has had successful careers as a public servant; in business as a chief executive; and as a lawyer and company chairman and director.

He is currently the chairman of five companies, including Hellaby Holdings, Kiwifruit International Ltd and Restaurant Brands New Zealand Limited, and a director of two.

Falconer currently serves as the chairman of the Meat Industry Association and also of the Market Surveillance Panel of the New Zealand Stock Exchange. His previous appointments include chairman of Maui Development Ltd, Natural Gas Corporation Ltd, St Lukes Group Ltd and the Accident Compensation Corporation.

"We are delighted that William Falconer has joined the Board of Tower. His commercial expertise and experience will be a valued addition to the strength of our board. I made the commitment to shareholders at the 2003 annual meeting that the Tower Board would be restructured and revitalised, and the appointment of William Falconer completes this process," Tower chairman Olaf O’Duill says.

Alan Eyes, who was elected to the Tower Board in 1999 will retire on December 31. Falconer’s appointment is effective from that time and he will be subject to re-election at the 2004 annual meeting. He will also be appointed to the board of Tower Finance Limited.

Bond Offer: Infratil Ltd, 7.2 year & 10.2 year unsecured unsubordinated bond


  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower FY profit jumps 67%, to return $120M to shareholders; shares jump
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy